Processa Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PCSA Nasdaq 2830 www.processapharmaceuticals.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline - Jul 29th, 2026 8:33 am
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS - Jul 29th, 2026 5:30 am
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - Jan 12th, 2026 7:15 am
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Jan 9th, 2026 7:00 am
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - Jan 5th, 2026 7:15 am
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Dec 26th, 2025 7:00 am
Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline - Dec 18th, 2025 7:23 am
Top Midday Gainers - Dec 17th, 2025 11:37 am
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer - Dec 17th, 2025 6:00 am
Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely? - Dec 17th, 2025 3:43 am
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 - Nov 5th, 2025 7:15 am